FA
TMO icon

Friess Associates’s Thermo Fisher Scientific TMO Stock Holding History

Friess Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-694
Closed -$410K – 83
2022
Q1 		$410K Buy
694
+151
+28% +$86.7K 0.22% 76
2021
Q4 		$362K Sell
543
-2,699
-83% -$1.69M 0.14% 82
2021
Q3 		$1.85M Buy
+3,242
New +$1.78M 0.78% 62
2021
Q2 		– Sell
-167
Closed -$76K – 108
2021
Q1 		$76K Sell
167
-45,770
-100% -$21.8M 0.03% 89
2020
Q4 		$21.4M Sell
45,937
-10
-0% -$4.69K 1.58% 33
2020
Q3 		$20.3M Sell
45,947
-2,087
-4% -$862K 1.76% 22
2020
Q2 		$17.4M Hold
48,034
– – 1.62% 18
2020
Q1 		$13.6M Hold
48,034
– – 1.36% 34
2019
Q4 		$15.6M Hold
48,034
– – 1.09% 47
2019
Q3 		$14M Buy
48,034
+4,650
+11% +$1.33M 1.08% 51
2019
Q2 		$12.7M Sell
43,384
-41,400
-49% -$11.4M 0.93% 50
2019
Q1 		$23.2M Sell
84,784
-230
-0.3% -$57.2K 1.7% 12
2018
Q4 		$19M Sell
85,014
-58
-0.1% -$13.6K 1.63% 16
2018
Q3 		$20.8M Buy
85,072
+233
+0.3% +$53.6K 1.45% 27
2018
Q2 		$17.6M Buy
84,839
+17,000
+25% +$3.61M 1.39% 32
2018
Q1 		$14M Sell
67,839
-25
-0% -$5.25K 1.14% 42
2017
Q4 		$12.9M Sell
67,864
-45,495
-40% -$8.72M 1.07% 47
2017
Q3 		$21.4M Buy
113,359
+1,140
+1% +$206K 1.88% 5
2017
Q2 		$19.6M Hold
112,219
– – 1.78% 4
2017
Q1 		$17.2M Sell
112,219
-2,314
-2% -$354K 1.62% 15
2016
Q4 		$16.2M Buy
114,533
+19
+0% +$2.8K 1.59% 22
2016
Q3 		$18.2M Hold
114,514
– – 1.76% 17
2016
Q2 		$16.9M Hold
114,514
– – 1.73% 20
2016
Q1 		$16.2M Sell
114,514
-43,986
-28% -$5.89M 1.62% 22
2015
Q4 		$22.5M Buy
158,500
+9,500
+6% +$1.27M 2.09% 5
2015
Q3 		$18.2M Hold
149,000
– – 1.69% 13
2015
Q2 		$19.3M Buy
+149,000
New +$19.4M 1.62% 13

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Friess Associates's TMO Position: Q2 2022 in Review

Friess Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 694 shares — an estimated $410K sold.

Friess Associates first reported a position in TMO in Q2 2015 and held it in 27 quarters. The position peaked at $23.2M in Q1 2019. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Friess Associates reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Friess Associates sold 694 Thermo Fisher Scientific shares in Q2 2022, an estimated $410K.
  • Friess Associates first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 27 quarters.
  • Friess Associates's Thermo Fisher Scientific position peaked at $23.2M in Q1 2019.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.